Abstract: Pathophysiological functions of cardiac cystic fibrosis transmembrane conductance regulator (cCFTR) in ischemia are not well known. Using neonatal rat ventricular cardiomyocytes in primary culture in this study, we thus examined whether the CFTR protein is expressed and is functioning as a cAMP-activated anion channel on the plasma membrane under ischemic conditions. After the cells were subjected to simulated ischemia (O 2 and glucose deprivation), an up-regulation of the CFTR expression was transiently observed in the membrane fraction by Western blot. A peak expression of mature CFTR protein was found at 3 h of ischemia, and thereafter the signal diminished gradually. In contrast, the results of Northern blot indicated that the expression level of CFTR mRNA changed little until 3 h of ischemia, whereas the level slightly decreased after 8 h of ischemia. An immunohistochemical examination showed, in agreement with the results of Western blot analysis, that the expression of CFTR protein on the plasma membrane became most prominent at 3 h of ischemia, whereas the plasmalemmal CFTR signal was markedly reduced after 8 h of ischemia. Whole-cell recordings showed that the cardiomyocytes responded to cAMP with an activation of time-and voltage-independent currents that contained an anion-selective component sensitive to CFTR Cl -channel blockers (NPPB and glibenclamide) but not to a stilbene-derivative conventional Cl Ϫ channel blocker (SITS). This cAMP-activated Cl Ϫ channel current was found to be enhanced after an application of ischemic stress for 3 to 4 h. These findings indicate that a plasmalemmal expression of CFTR is transiently enhanced under glucose-free hypoxic conditions presumably because of a posttranslational control. [The Japanese Journal of Physiology 53: [357] [358] [359] [360] [361] [362] [363] [364] [365] 2003] segment in the first cytoplasmic loop of epithelial CFTR [12, 13] . Finally this gene was demonstrated to actually encode a cAMP-dependent Cl Ϫ channel [13, 14] .
A first clue of a possible physiological role of cardiac CFTR was provided by the report that the action potential duration became shortened by stimulation with forskolin, and this effect was antagonized by a CFTR Cl Ϫ channel blocker, glibenclamide [15] . The stimulation of ␤ 3 -adrenoceptors was also observed to reduce the action potential duration in human myocytes obtained from non-CF patients, but not in myocytes from ⌬F508 CF patients [16] . Under ␤-adrenergic stimulation, the CFTR Cl Ϫ conductance was shown to be involved in the regulatory volume decrease in osmotically swollen cardiomyocytes of guinea pig [17, 18] . However, it is not yet clear whether significant electrocardiogram abnormalities may occur, especially during strong sympathetic stress, such as ischemia, in CF patients [19] . Since several case studies [20, 21] previously reported that myocardial necrosis and fibrosis is a rare complication of CF causing sudden and unexpected death in infancy as a result of cardiac arrest, there is a possibility that CFTR plays some pathophysiological role. We here studied changes in the CFTR expression in cardiomyocytes during ischemia to address a role of CFTR in ischemic injury.
Since cellular protein synthesis and RNA synthesis are major energy-consuming pathways, they should be downregulated during severe hypoxia, when oxygen concentrations are low enough to induce energetic stress. In fact, severe hypoxia (Ͻ0.05% O 2 ) was found to lead to a downregulation of protein synthesis and RNA synthesis in neonatal rat cardiomyocytes [22] . Also, the expression of mature epithelial CFTR in the human airway epithelium was downregulated by ATP depletion induced by the addition of respiratory and glycolytic inhibitors [23] . However, there has been no study on changes in the expression of cardiac CFTR under ischemic conditions. Therefore the present study was performed to address whether cardiac CFTR is expressed and functioning as a Cl Ϫ channel in neonatal rat cardiomyocytes and whether the molecular and functional expression of cardiac CFTR is altered by ischemia.
MATERIALS AND METHODS
Neonatal rat ventricular myocyte preparation. The experimental design was approved in advance by the Ethics Review Committee for Animal Experimentation of the National Institute for Physiological Sciences. The investigation conforms also with the Guiding Principles of the Physiological Society of Japan. The primary cultures of neonatal rat cardiac myocytes were prepared by a modification of a protocol reported previously [24] . In brief, the hearts were removed from neonatal rats (day 4), and the ventricles were minced in 0.05% trypsin-EDTA (Gibco, NY, USA). These tissue fragments were digested by stepwise trypsin-induced dissociation at 37°C in a CO 2 incubator. To reduce the number of contaminating nonmyocardial cells, the dissociated cells were pre-plated for 1 h. The nonadherent myocytes were then plated onto the collagen-coated substrate at a density of 7ϫ10 5 /cm 2 for a dish. The cells were cultured in plating medium consisting of M199 supplemented with 10% fetal bovine serum. The final myocyte cultures were assessed to contain Ͼ90% cardiac myocytes by immunostaining with ␣-sarcomeric actin antibody (Sigma, St. Louis, MO, USA). The cells were maintained at 37°C in the presence of 5% CO 2 in a humidified incubator. Bromodeoxyuridine (BrdU 0.1 mmol/l) was included in the medium after plating to inhibit fibroblast growth. The culture medium was changed on day 1. BrdU was present continuously except during the experiment period. The cells were provided for experiments 4 d after culture.
Ischemic treatment. Ischemic stress was given by incubating cultured cardiomyocytes for a given time (1 to 8 h) in glucose-free solution and by placing the culture dish in an airtight incubator where normal air was replaced with a gas mixture of 95% Ar and 5% CO 2 . The glucose-free solution contained (mM) 108 NaCl, 5.4 KCl, 0.5 MgCl 2 , 1 CaCl 2 , 5 HEPES, and 2.5 Tris (pH adjusted to 7.4 with NaHCO 3 ; osmolality adjusted with mannitol to 300 mosmol/kg-H 2 O). The pO 2 of the ischemic solution in the culture dish was found to reach a level of Ͻ10 mmHg by a pO 2 probe (LICOX cmp: GMS, Mielkendorf, Germany). The control experiments were performed by exposing cardiomyocytes to the above solution supplemented with 10 mM glucose for 3 or 8 h in the incubator equilibrated with 95% air and 5% CO 2 .
Western blot analysis. Subconfluent cardiomyocytes, pretreated with or without ischemia, were scraped into buffer (10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA), and a protease inhibitor cocktail (Complete, Mini, EDTA-free Tablet: Roche Molecular Biotech UK, Buckinghamshire, UK) and sonicated. Postnuclear supernatants were obtained by centrifugation (15,000 rpm for 30 min at 4°C). The membrane fraction was obtained by centrifugation of the postnuclear supernatants at 100,000ϫg for 60 min at 4°C. The pellet was dissolved in lysis buffer (50 mM Tris-HCl [pH 7.4], 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, and 1 mM EGTA) supplemented with protease inhibitors at 4°C overnight, and sonicated after suspension. Then the membrane proteins were obtained by centrifugation at 15,000 rpm for 10 min at 4°C. After the protein concentration was measured, the membrane lysate containing an equal amount of protein was subjected to SDS-PAGE using 7.5% polyacrylamide gels, and transferred to PVDF membranes. The blocking and reaction with antibody were performed by using the Enhanced Chemiluminescence System (Amersham Bioscience, Buckinghamshire, UK) according to the manufacturer's instructions. The blots were incubated with monoclonal anti-CFTR antibodies (clone M3A7: Upstate Biotechnology, Lake Placid, NY, USA) at room temperature for 1 h. For antibody detection, horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham Bioscience) and detection solution were used. Enhanced chemiluminescences were exposed to Hyperfilm TM ECL TM (Amersham Bioscience) for an appropriate duration. For positive control, HEK293T cells transfected with WT CFTR were used, as described previously [25] . The relative values of integrated optical densities of the bands were quantified by using an image software (Scion Corp., Frederick, MD, USA). Since actin, which is generally used as the control protein, was markedly decreased by ischemic treatment (data not shown), the data were normalized by the whole protein in the sample.
Northern blot analysis. Total RNA was isolated from subconfluent cardiomyocytes by using Sepasol II Super according to the manufacturer's protocol (Nacalai Tesque, Kyoto, Japan). Aliquots of 10 g of total RNA were separated by 1.5% agarose-formaldehyde gel electrophoresis. The RNA was transferred onto positively charged nylon membranes and then UV-cross-linked. The nylon membranes were then hybridized with a biotinylated probe for human CFTR RNA or rat GAPDH RNA at 50°C in buffer containing 50% formamide. After being washed and blocked, the membranes were incubated with HRP-conjugated streptavidine for 1 h. After extensive washing, they were incubated with the HRP substrate and exposed to X-ray film for the detection of specific bands of rat CFTR mRNA according to the manufacture's protocol of the Non-Rad Detection Kit (BD Bioscience, CA, USA). The biotinylated RNA probes corresponding to the 133-621 bp derived from human CFTR cDNA clone and to the 548-990 bp for rat GAPDH cDNA were prepared with an in vitro transcription kit (BD Bioscience).
Immunofluorescence. To analyze the localization of CFTR on the plasma membrane, a cell-surface labeling technique with the lectin, wheat germ agglutinin (WGA: EY Laboratories, INC, San Mateo, CA, USA) was used as reported previously [26] . The cells cultured on coverslips were fixed with methanol for 10 min at Ϫ20°C. They were then washed with PBS, incubated with FITC-conjugated lectins before permeabilization, and washed three times with PBS. They were permeabilized with PBS containing 0.2% TritonX-100 for 10 min, washed three times with PBS, and soaked in a blocking solution (PBS containing 4% normal donkey serum) for 1 h. Subsequently they were incubated with polyclonal anti-CFTR goat antibodies (N-20: Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) as a primary antibody for 1 h and washed three times with PBS. The cells were then incubated with rhodamine red-X-conjugated donkey anti-goat IgG (1 : 50 dilution; Jackson Immunoresearch, West Grove, PA, USA) as the secondary antibody for 30 min, followed by washing with PBS. They were then embedded in 90% glycerol-PBS containing 0.1% p-phenylendiamine and 1% n-propyl gallate. The fluorescence images of stained samples were visualized with a laser confocal microscope (MRC1024; Bio Rad, Hercules, CA, USA). As the negative control, 1% albumin-PBS was applied instead of anti-CFTR.
Electrophysiology. Whole-cell recordings were performed, as described previously [27] , with wide-tipped electrodes. The patch electrodes were fabricated from borosilicate glass capillaries by using a micropipette puller (Sutter Instrument, Novato, CA, USA). Electrodes filled with pipette solution had a resistance of about 2 M⍀. Series resistance (usually Ͻ5 M⍀) was compensated (to 60 to 75%) to minimize voltage errors. The currents were recorded with an Axopatch 200A amplifier (Axon Instruments, Foster City, CA, USA), filtered at 1 kHz with a four-pore Bessel filter installed in the amplifier and digitized at 4 kHz. The PCLAMP software (version 6.0.2, Axon Instruments) was used for command pulse control, data acquisition, and analysis. The time course of current activation and recovery was monitored by repetitively applying (every 15 s) ramp pulses (1.5 s duration) to Ϯ80 mV for cAMP-activated Cl Ϫ currents from a holding potential of 0 mV. The time-and voltage-independent properties of cAMP-activated Cl Ϫ currents were examined by applying step pulses (1 s duration) from Ϫ80 to ϩ80 mV in 20-mV increments. The amplitude of instantaneous current was measured 2.5 ms after the step pulse onset. The patch pipette contained (in mM) 85 CsCl, 10 EGTA, 20 TEA-Cl, 5 MgATP, 3 phosphocreatine-Na 2 , 0. Ϫ conditions, where NaCl in bath solution was replaced with Na-gluconate. When bath Cl Ϫ concentration was altered, a salt bridge containing 3 M KCl in 2% agarose was used to minimize variations in bath electrode potential. CFTR Cl Ϫ currents were activated by applying a cAMP-stimulating cocktail containing 1 mM dbcAMP, 0.5 M 3-isobutyl-1-methylxanthine (IBMX), and 10 M forskolin (FSK).
All experiments were performed at room temperature (20-25°C).
Data analysis. All data are summarized and expressed as meanϮSEM. Statistical differences of the electrophysiological and densitometric data were evaluated by Student's t-test and considered significant at pϽ0.05.
RESULTS

The effects of ischemia on the molecular expression of cardiac CFTR
Although the expression of the CFTR protein in neonatal rat ventricular myocytes was previously evidenced by Western blot [28] , the effects of ischemic stress on the expression have never been investigated in the cardiomyocytes. Therefore the time-dependent effects of ischemia on the CFTR protein expression were first observed by Western blotting. As shown in Fig. 1A -a, the bands reactive to anti-CFTR antibodies were detected before and after ischemic treatment for 1 to 8 h. The control experiments using HEK293T cells transfected with WT CFTR showed that the bands at around 180 (upper arrowhead) and 140 kDa (lower arrowhead) correspond to mature and immature CFTR proteins, respectively (data not shown). The expression level of CFTR protein changed with periods of ischemic treatment. A peak expression of mature CFTR protein was found at 3 h of ischemia, and thereafter the bands became gradually faint. As summarized in Fig. 1A-b , relative optical densities of the bands for mature CFTR after 3 and 8 h of ischemia were 166.1Ϯ7.8 (pϽ0.01) and 44.4Ϯ7.8% (pϽ0.01), compared with the control (0 h). Immature CFTR also showed time-dependent changes in the expression similar to mature CFTR, though transient enhancement at 3 h of ischemia was less prominent. In contrast, the Northern blot analysis showed that the expression level of CFTR mRNA changed little through 0 to 3 h during ischemia but slightly decreased after 8 h of ischemia (Fig. 1B) . It is noted that the GAPDH mRNA level was also unchanged up 
h and was decreased at 8 h of ischemia.
To detect an expression of the CFTR protein on the plasma membrane before and during the application of ischemic stress, we then performed dual staining by using a polyclonal anti-CFTR antibody and WGA, which binds to the glycoside residue on the plasma membrane. The site of CFTR expression was compared to the plasmalemmal WGA staining under confocal microscopy. As shown in Fig. 2 , most signals of the CFTR protein were found to colocalize with WGA-reactive proteins on the plasma membrane at 3 h of ischemia, but the CFTR signal was prominently reduced at 8 h. These findings are in agreement with the time course of mature CFTR protein expression in the membrane fraction detected by Western blot (Fig.  1A) .
Control experiments showed that no significant change was found in the reactivity of cardiomyocytes to anti-CFTR antibody and WGA 3 or 8 h after incubation in glucose-containing solution equilibrated with 95% air and 5% CO 2 (data not shown, nϭ2).
Taken together, it is concluded that the mature CFTR protein is expressed on the plasma membrane throughout the 8 h ischemic period, and that shortterm (3 h) ischemia induces a transient enhancement of the expression of mature CFTR proteins presumably by the posttranslational control in neonatal rat cardiomyocytes.
Ischemia Enhances CFTR Expression 
The effects of ischemia on the functional expression of cardiac CFTR
To examine whether mature CFTR proteins function as cAMP-activated Cl Ϫ channels on the plasma membrane in cardiomyocytes, patch-clamp whole-cell recordings were performed. Stimulation with a cAMP cocktail resulted in the activation of whole-cell currents recorded in cardiomyocytes under control conditions (Fig. 3A) . The current responses to step pulses were time-independent (Fig. 3A-a) . The current-voltage (I-V) curve exhibited a linear relationship (Fig.  3A-b) . These characteristics are in good agreement with those of cAMP-activated anion conductance associated with the CFTR expression in neonatal rat cardiomyocytes [28, 29] . The time-independent, I-V linear current became more prominent in cardiomyocytes after applying ischemic stress for 3 to 4 h (Fig.  3B) .
As shown in Fig. 4 , the cAMP-activated currents recorded from ischemic cardiomyocytes were significantly, though in part, suppressed by a CFTR channel blocker, NPPB or glibenclamide, but were never affected by an extracellular application of a conventional Cl Ϫ channel blocker, SITS, which is known to be ineffective for the CFTR Cl Ϫ channel. A reduction of extracellular Cl Ϫ concentration (from 111 to 8 mM) induced a rightward shift (by 6.4Ϯ1.2 mV, nϭ3) of the reversal potential (Fig. 4C) , although the shift was much less than that theoretically predicted for pure Cl Ϫ conductance (61.5 mV). These results indicate that the cAMP-activated time-and voltage-independent currents contained a sizable component of CFTR Cl Ϫ channel current together with a remaining component of non-anionic current insensitive to NPPB, glibenclamide, and SITS, and that the functional expression of plasmalemmal CFTR was enhanced by ischemic stress for 3 to 4 h in cardiomyocytes.
DISCUSSION
In the guinea pig and rabbit cardiac myocytes, a stimulation of the ␤-adrenergic receptor leads to the activation of a cAMP-activated Cl Ϫ channel [10, 11, [30] [31] [32] . The functional properties of this channel were found to be similar to those of the epithelial CFTR Cl Ϫ channel [15, [33] [34] [35] [36] . Indeed, the cardiac form of CFTR (cCFTR) gene was cloned [13] and demonstrated to encode a cAMP-activated Cl Ϫ channel [13, 14] species [19] , the CFTR Cl Ϫ channel activity in ventricular cells has been demonstrated not only in the guinea pig and rabbit, but also in several other mammalian species, including the neonatal rat [29] and mouse [37] and the adult mouse [38] . The present study confirmed the molecular and functional expression of cCFTR on the plasma membrane in neonatal rat cardiomyocytes by Western blot (Fig. 1A) , immunohistochemical analysis (Fig. 2) and whole-cell current recordings (Fig. 3) .
In the human heart, a cAMP-activated Cl Ϫ current has not been detected [39, 40] , whereas the CFTR mRNA [39] and CFTR immunoreactivity [41] were. However, a stimulation of ␤ 3 -adenoceptors was found to reduce the action potential duration in human cardiomyocytes obtained from non-CF patients but not from ⌬F508 CF patients [16] , suggesting an induction of CFTR Cl Ϫ channel activity by catecholamine stimulation. Catecholamines are known to be released under ischemic conditions [42, 43] . The present study showed that O 2 and glucose deprivation (for 3 to 4 h) induces the transient enhancement of plasmalemmal expression of cCFTR (Figs. 1A and 2 ) and of the activity of cAMP-dependent Cl Ϫ channel (Figs. 3 and 4) in neonatal rat cardiomyocytes.
The mechanism of the ischemia-induced transient upregulation of the plasmalemmal expression of the CFTR Cl Ϫ channel is unknown. Intracellular cAMP was reported to increase the expression of the CFTR mRNA in colonic HT-29 cells [44] . However, the CFTR mRNA level changed little up to 3 h after ischemic treatment in neonatal rat cardiomyocytes in the present study (Fig. 1B) . Further studies are required for an elucidation of this posttranslational control mechanism.
In contrast to the upregulation effect of short-term ischemia, the long-term (8 h) application of ischemic stress was found to downregulate the expression of CFTR proteins (Figs. 1A and 2 ) and of mRNAs for CFTR and for a house-keeping protein, GAPDH, (Fig.  1B) in neonatal rat cardiomyocytes. These observations are consistent with a previous report [22] that protein synthesis and RNA synthesis were both downregulated as a result of ATP depletion only during severe hypoxia in neonatal cardiomyocytes.
Cardiac cell swelling was reported to be induced by an accumulation of anaerobic metabolites during ischemia [45] [46] [47] . Recently, a preconditioning-induced facilitation of volume regulation has been reported to be involved in the protection mechanism against ischemic injury in rabbit ventricular cardiomyocytes [48] . In guinea pig ventricular cardiomyocytes, the regulatory volume decrease was shown to be induced only when the CFTR Cl Ϫ channel was activated by ␤-Ischemia Enhances CFTR Expression Fig. 4 . Patch-clamp studies for the sensitivity of cAMP-activated whole-cell currents to Cl ؊ channel blockers and to a reduction of the extracellular Cl ؊ concentration in ischemic cardiomyocytes. Whole-cell currents recorded in cardiomyocytes subjected to ischemic stress for 3 to 4 h. A: Representative whole-cell currents activated at a Ϯ80 mV by a cAMP cocktail before, during, and after an application of Cl Ϫ channel blockers (300 M SITS and 100 M NPPB). Thick bars represent the application periods of cAMP cocktail, SITS, and NPPB. B: The effects of Cl Ϫ channel blockers (100 M NPPB, 500 M glibenclamide, and 300 M SITS) on cAMP-activated whole-cell currents recorded at Ϯ80 mV. The background currents recorded immediately before the application of cAMP cocktail were subtracted. *Significantly differ at pϽ0.05 from the control data (without adding blockers). C: The effects of the reduction of extracellular Cl Ϫ concentration on cAMP-activated wholecell currents. The currents were recorded in symmetrical (111 mM/111 mM) or asymmetrical (111 mM/8 mM) Cl Ϫ conditions.
adrenergic stimulation [17] . The question thus arises as to whether the short-term ischemia-induced upregulation of the molecular and functional expression of plasmalemmal mature CFTR is involved in the protection mechanism of ischemic preconditioning via the facilitation of volume regulation, thereby preventing the necrotic volume increase (NVI), which is an early step of necrosis [49] . This question remains to be addressed in future studies.
